- Home
- SINT vs TRAW Comparison
SINT vs TRAW Comparison
Compare SINT & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- TRAW
- Stock Information
- Founded
- SINT 1996
- TRAW 1998
- Country
- SINT United States
- TRAW United States
- Employees
- SINT N/A
- TRAW N/A
- Industry
- SINT Medical/Dental Instruments
- TRAW
- Sector
- SINT Health Care
- TRAW
- Exchange
- SINT Nasdaq
- TRAW NYSE
- Market Cap
- SINT 7.9M
- TRAW 7.8M
- IPO Year
- SINT 2014
- TRAW 2013
- Fundamental
- Price
- SINT $2.84
- TRAW $1.65
- Analyst Decision
- SINT Strong Buy
- TRAW
- Analyst Count
- SINT 1
- TRAW 0
- Target Price
- SINT $28.00
- TRAW N/A
- AVG Volume (30 Days)
- SINT 334.3K
- TRAW 3.5M
- Earning Date
- SINT 05-15-2025
- TRAW 05-15-2025
- Dividend Yield
- SINT N/A
- TRAW N/A
- EPS Growth
- SINT N/A
- TRAW N/A
- EPS
- SINT N/A
- TRAW N/A
- Revenue
- SINT $2,569,000.00
- TRAW $227,000.00
- Revenue This Year
- SINT $3.26
- TRAW $3.81
- Revenue Next Year
- SINT $21.87
- TRAW $30.43
- P/E Ratio
- SINT N/A
- TRAW N/A
- Revenue Growth
- SINT N/A
- TRAW 0.44
- 52 Week Low
- SINT $1.71
- TRAW $0.97
- 52 Week High
- SINT $8.60
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- SINT 52.40
- TRAW 54.15
- Support Level
- SINT $2.66
- TRAW $1.30
- Resistance Level
- SINT $2.92
- TRAW $2.58
- Average True Range (ATR)
- SINT 0.22
- TRAW 0.23
- MACD
- SINT -0.02
- TRAW 0.07
- Stochastic Oscillator
- SINT 43.02
- TRAW 34.04
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.